middle.news
Pfizer’s newer medicines gain ground as COVID-19 sales retreat
12:07am on Wednesday 4th of November, 2026 AEDT
•
Pharmaceuticals
Read Story
Pfizer’s newer medicines gain ground as COVID-19 sales retreat
12:07am on Wednesday 4th of November, 2026 AEDT
Key Points
2026 revenue guidance raised to US$62.0 billion-US$64.0 billion
Adjusted diluted EPS guidance lifted to US$2.95-US$3.05
Launched and acquired products grew 32% operationally
Comirnaty and Paxlovid revenue fell by a combined US$1.1 billion
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Pfizer (NYSE:PFE)
OPEN ARTICLE